Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient‐derived xenografts
Vilma Dembitz(University of Zagreb), Paolo Gallipoli(Wellcome/MRC Cambridge Stem Cell Institute), Hannah Lawson(University of London), Kamil R. Kranc(Institute of Cancer Research), Joana Campos(Queen Mary University of London), Jozef Durko(Queen Mary University of London), Sophie C. James(Queen Mary University of London)
Cited by 4
Related Papers
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
|Cell Reports|2016|834
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
|Cell stem cell|2019|552
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
|The Journal of Experimental Medicine|2020|145
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions
|The Journal of Experimental Medicine|2017|85